143 related articles for article (PubMed ID: 9881875)
1. Tumour necrosis factor alpha induces only minor inflammatory changes in the central nervous system, but augments experimental meningitis.
Angstwurm K; Freyer D; Dirnagl U; Hanisch UK; Schumann RR; Einhäupl KM; Weber JR
Neuroscience; 1998 Sep; 86(2):627-34. PubMed ID: 9881875
[TBL] [Abstract][Full Text] [Related]
2. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats.
Pfister HW; Koedel U; Lorenzl S; Tomasz A
Stroke; 1992 Dec; 23(12):1798-804. PubMed ID: 1448831
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis.
Lorenzl S; Koedel U; Frei K; Bernatowicz A; Fontana A; Pfister HW
J Infect Dis; 1995 Jul; 172(1):113-8. PubMed ID: 7797900
[TBL] [Abstract][Full Text] [Related]
5. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
6. Methylprednisolone attenuates inflammation, increase of brain water content and intracranial pressure, but does not influence cerebral blood flow changes in experimental pneumococcal meningitis.
Koedel U; Pfister HW; Tomasz A
Brain Res; 1994 Apr; 644(1):25-31. PubMed ID: 8032946
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
8. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat.
Lorenzl S; Koedel U; Pfister HW
Crit Care Med; 1996 Nov; 24(11):1874-80. PubMed ID: 8917039
[TBL] [Abstract][Full Text] [Related]
9. Induced hypothermia in experimental pneumococcal meningitis.
Angstwurm K; Reuss S; Freyer D; Arnold G; Dirnagl U; Schumann RR; Weber JR
J Cereb Blood Flow Metab; 2000 May; 20(5):834-8. PubMed ID: 10826534
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal meningitis.
Pfister HW; Frei K; Ottnad B; Koedel U; Tomasz A; Fontana A
J Exp Med; 1992 Jul; 176(1):265-8. PubMed ID: 1613460
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide.
Tureen J
J Clin Invest; 1995 Mar; 95(3):1086-91. PubMed ID: 7883956
[TBL] [Abstract][Full Text] [Related]
12. Fucoidin, a polysaccharide inhibiting leukocyte rolling, attenuates inflammatory responses in experimental pneumococcal meningitis in rats.
Angstwurm K; Weber JR; Segert A; Bürger W; Weih M; Freyer D; Einhäupl KM; Dirnagl U
Neurosci Lett; 1995 May; 191(1-2):1-4. PubMed ID: 7659273
[TBL] [Abstract][Full Text] [Related]
13. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat.
Lorenzl S; Ködel U; Frei K; Pfister HW
Eur J Pharmacol; 1996 Jul; 308(3):335-41. PubMed ID: 8858309
[TBL] [Abstract][Full Text] [Related]
14. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?
Haberl RL; Anneser F; Ködel U; Pfister HW
Neurol Res; 1994 Apr; 16(2):108-12. PubMed ID: 7913993
[TBL] [Abstract][Full Text] [Related]
15. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis.
Pfister HW; Ködel U; Dirnagl U; Haberl RL; Ruckdeschel G; Einhäupl KM
J Infect Dis; 1992 Dec; 166(6):1442-5. PubMed ID: 1431262
[TBL] [Abstract][Full Text] [Related]
16. Bacterial hydrogen peroxide contributes to cerebral hyperemia during early stages of experimental pneumococcal meningitis.
Hoffmann OM; Becker D; Weber JR
J Cereb Blood Flow Metab; 2007 Nov; 27(11):1792-7. PubMed ID: 17311075
[TBL] [Abstract][Full Text] [Related]
17. Cerebral blood flow autoregulation in early experimental S. pneumoniae meningitis.
Pedersen M; Brandt CT; Knudsen GM; Ostergaard C; Skinhøj P; Frimodt-Møller N; Møller K
J Appl Physiol (1985); 2007 Jan; 102(1):72-8. PubMed ID: 17008439
[TBL] [Abstract][Full Text] [Related]
18. 7-Nitroindazole, but not aminoguanidine, attenuates the acute inflammatory responses and brain injury during the early phase of Escherichia coli meningitis in the newborn piglet.
Park WS; Chang YS; Lee M
Biol Neonate; 2001 Jul; 80(1):53-9. PubMed ID: 11474150
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of tyrosine phosphatase SHP2 in experimental pneumococcal meningitis: correlation with tumor necrosis factor-alpha and cerebrospinal fluid pleocytosis.
Feng M; Sun R; Zhang C; Sun E; Wei S; Wan J; Sun R
J Child Neurol; 2008 Mar; 23(3):287-92. PubMed ID: 18305318
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal cell wall components induce nitric oxide synthase and TNF-alpha in astroglial-enriched cultures.
Freyer D; Weih M; Weber JR; Bürger W; Scholz P; Manz R; Ziegenhorn A; Angestwurm K; Dirnagl U
Glia; 1996 Jan; 16(1):1-6. PubMed ID: 8787768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
